What is TKNO's market cap?

$454.75M, based on the Nov 4 close of $7.37.

Does Alpha Teknova pay a dividend?

No regular cash dividend has been paid in the last year.

How much of TKNO is sold short?

1.6M shares, 19.5% of float, as of Oct 15, 2026.

What sector is TKNO in?

Healthcare, in the Diagnostics industry.

NASDAQ · TKNOHealthcareDiagnostics

Alpha Teknova, Inc. Common Stock (TKNO)

$7.37+0.41%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$7.37▲ 55.16% in range

Nov 4, 2025Low $1.99 · High $9.33Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Alpha Teknova closed at $7.37 on Nov 4, up 0.41%, 21.0% below its 52-week closing high. Volume of 372.3K shares was 0.50× its 20-day average (below normal).

Split-adjusted performance: -15.8% over one month, +102.5% over six months, +45.1% over one year.

In the quarter ended Jun 30, 2026, revenue was $12.19M, up 18.5% from a year earlier, with a net margin of -26.0%.

Short interest was 1.6M shares at the Oct 15 settlement (19.5% of float, 5.8 days to cover).

Market cap$454.7M61.7M shares

Revenue · quarter$12.2M+18.5% YoY

Diluted EPS$-0.06—

P/E · TTM—P/S 10.4×

Net margin-26.0%Gross 40.1%

Dividend yieldNone

52-week range1.99 – 9.33−21.0% from high

Volume372.3K0.50× 20-day avg

Volatility · 60d79.6%Annualised

Short % of float19.5%5.8 days to cover

Net cash$4.2MCash $17.4M

Next earnings—Not scheduled

Split-adjusted performance

1W −6.2%1M −15.8%3M +12.9%6M +102.5%YTD +93.9%1Y +45.1%3Y +298.4%5Y −67.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Diagnostics

Percentile among 15 companies (100 = best)

6-month momentum100

Revenue growth100

Net margin50

Value (low P/E)—

Size43

Industry medians: 6-month return +17.4%, revenue growth −2.0%, net margin −26.0%, P/E 46.6×.

Short interest

Details →

Shares short1.6M+0.9% vs prior

Days to cover5.8Settled Oct 15

% of float19.5%

Short vol. 10d39.6%of daily volume

Closest peers by size in Diagnostics

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
TKNOAlpha Teknova	$7.37	+0.41%	+102.5%	+18.5%	−26.0%	—	$454.7M
MYGNMyriad Genetics	$6.02	−0.33%	+46.5%	−10.5%	−22.7%	—	$575.8M	Compare
ACHVAchieve Life Sciences	$6.98	+3.71%	+45.4%	—	—	—	$719.7M	Compare
QDELQuidelOrtho	$14.35	+1.85%	+30.9%	+2.8%	−14.7%	—	$984.1M	Compare
NTLAIntellia Therapeutics	$12.31	+3.79%	−11.1%	−46.2%	−1392.3%	—	$1.72B	Compare
ICCCImmucell	$10.37	+1.17%	+19.7%	+11.5%	25.5%	119.6	$94.2M	Compare
CLDXCelldex Therapeutics	$29.93	+0.74%	−13.0%	−97.0%	−334104.5%	—	$2.35B	Compare
IMDXInsight Molecular Diagnostics	$2.65	−3.28%	−47.3%	−53.9%	−4711.3%	—	$86.7M	Compare
NEOGNeogen	$12.46	+2.98%	+35.7%	+6.5%	−5.3%	—	$2.72B	Compare

News about Alpha Teknova

All news →

Alpha Teknova (TKNO) Stock Jumps 5.1%: Will It Continue to Soar?Zacks Investment Research · Oct 23, 2026Neutral Teknova to Report Third Quarter 2026 Financial Results on November 4, 2026GlobeNewswire Inc. · Oct 21, 2026Neutral Teknova Announces Pricing of $40 Million Public Offering of Common StockGlobeNewswire Inc. · Oct 21, 2026▲ Positive All You Need to Know About Alpha Teknova (TKNO) Rating Upgrade to BuyZacks Investment Research · Oct 1, 2026▲ Positive

Quick answers

What does Alpha Teknova do?: Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions.
What is TKNO's market cap?: $454.75M, based on the Nov 4 close of $7.37.
Does Alpha Teknova pay a dividend?: No regular cash dividend has been paid in the last year.
How much of TKNO is sold short?: 1.6M shares, 19.5% of float, as of Oct 15, 2026.
What sector is TKNO in?: Healthcare, in the Diagnostics industry.

About Alpha Teknova

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

HQ: Hollister, CA158 employeesListed Jun 25, 2021teknova.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology